Category Archives: OTC Switches

Good Time to Move on Plan B

Last week, former Acting Commissioner and former Commissioner Lester B. Crawford admitted in a deposition that he acted to pre-empt FDA staff from approving the OTC switch of Plan B, according to a report in the Baltimore Sun.  What he … Continue reading

Posted in FDA Policy, OTC Switches | Comments Off

Statins and The RX to OTC Switch Pipeline

As mentioned yesterday, the increase in the number of patent expirations set for the next few years indicates an opportunity for an increase in RX to OTC switches.  In March, I had a posting on the challenges in the current … Continue reading

Posted in OTC Switches | 3 Comments

The RX to OTC Switch Environment

There are fewer drugs available for switching from prescription to over-the counter status than there have been in years gone by. Several years ago I was involved providing counsel on the largest switch of a drug from prescription (RX) to … Continue reading

Posted in OTC Switches | 1 Comment